Overview

Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients

Status:
Suspended
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This phase II study is to evaluate the efficacy of SR-T100 gel in complete clearance of target warts at different concentrations (1.0% and 2.3% of SM in Solanum undatum plant extract) in patients with CW.
Phase:
Phase 2
Details
Lead Sponsor:
G&E Herbal Biotechnology Co., LTD